Chang et al. demonstrated that RUNX2 was overexpressed in HNSCC samples (Chang et al., 2017) and could serve as a poor prognostic marker in HNSCC (Chang et al., 2016). This evidence concerns the gene RUNX2 and head and neck squamous cell carcinoma.